THC in Seizure Models, Lifestyle Behaviors, and Offspring Health Data
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Mobile Intervention Tools, Sex Differences, and Digital Health in Cannabis Care
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Clinician Practice Companions and Patient Outcomes in Real-World Registries
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Cannabis Dosing Needs More Than Guesswork
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "Cannabis Dosing Needs More Than Guesswork", "articleBody": "Cannabis has a…
Cannabinoids in Oncology: Preclinical Signals, Tumor Pathways, and Clinical Trials
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Patent Watch: Cryogenic Cannabinoid Nanoparticles
The application claims a process for producing cannabinoid nanoparticles under cryogenic conditions and incorporating them into beverage compositions. Cannabinoids serve as the active ingredients, while nanoparticle engineering and the beverage matrix…
Cannabis Care Needs Evidence and Respect for the Plant
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "Cannabis Care Needs Evidence and Respect for the Plant", "articleBody":…
Federal Rule Moves Approved Marijuana Medicines to Schedule III
{ "@context": "https://schema.org", "@type": [ "NewsArticle", "MedicalWebPage" ], "headline": "Federal Rule Moves Approved Marijuana Medicines to Schedule III",…
Patent Watch: Kare Claims New Cannabinoid Derivati
The application claims cannabinoid derivatives, related chemical precursors, and potential uses, with classifications suggesting modified cannabinoid ring structures and organosilicon-containing intermediates. These compounds may function as potential…
Patent Watch: Nutramax Targets Cannabis Combinatio
The application appears to cover formulations combining cannabis-derived material with one or more additional pharmacologically active components, with inflammation identified as a therapeutic focus. The published classification data suggest a…
